Alasdair Naylor is a pharmacologist with over 30 years of experience. He gained his expertise at Pfizer and Solace Pharmaceuticals. More, he is the founder of a new start-up pain company, Sevenless Therapeutics. In addition to holding senior positions in these companies, Alasdair Naylor has consulted widely in the biotech and venture sector. He advised on target validation, translational research, and incorporating this knowledge into robust research plans for implementation. Alasdair has led multiple drug discovery and early clinical development teams. This has led to numerous positive proof of concepts in Urology, neuroscience, and inflammation. Further, he published 50+ scientific papers. Besides that, he is an author on Pfizer and Sevenless Therapeutics patents.
